Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06070688 · ClinicalTrials.gov registry record · NA
An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.
A NA study of Respiratory Tract Infections, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06070688 is a NA study of Respiratory Tract Infections that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 100 participants, below the 2,768-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06070688, a NA study of Respiratory Tract Infections, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate overall changes in patient management and longer-term resource utilization between control and test arms, including (but not limited to) additional work-up (including other diagnostic tests and consults), antimicrobial treatments, disposition decisions and hospital length of stay (LOS)
Conditions Studied
Interventions
- DIAGNOSTIC_TEST MeMed BV® biomarker test
- DIAGNOSTIC_TEST Usual care
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-12-11 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06070688
The ClinicalTrials.gov registry entry for NCT06070688 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,768-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (96% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Respiratory Tract Infections appearing as the primary indexed condition, and to 2 interventions - of which MeMed BV® biomarker test is the first listed.
NCT06070688 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06070688 about?
NCT06070688 is a clinical study titled "An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.". The purpose of this study is to evaluate overall changes in patient management and longer-term resource utilization between control and test arms, including (but not limited to) additional work-up (including other diagnostic tests and consults), antimicrobial treatments, disposition decisions and ho...
What is the current status of trial NCT06070688?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-12-11. Estimated completion is 2026-12-31.
What conditions does trial NCT06070688 study?
This clinical trial studies the following conditions: Respiratory Tract Infections.
What interventions are being tested in trial NCT06070688?
The interventions under investigation include: MeMed BV® biomarker test (DIAGNOSTIC_TEST), Usual care (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06070688?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06070688 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses
RECRUITING · NA
-
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
RECRUITING · NA
-
Vitamin D3 Supplementation to Prevent Respiratory Tract Infections
COMPLETED · NA
-
Patient Portal Flu Vaccine Reminders (RCT 6)
COMPLETED · NA
-
Measuring the Influence of Kefir on Children's Stools on Antibiotics (MILK)
COMPLETED · NA
-
Hand Hygiene Randomized Cluster Intervention to Reduce Infections
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.